Lv7
5010 积分 2024-02-04 加入
kinetics and determinations of esr1 mutation detection in metastatic breast cancer
1天前
已关闭
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial
19天前
已完结
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
20天前
已完结
CDK4/6 inhibitors in HER2-positive breast cancer
21天前
已完结
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
21天前
已完结
Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial
22天前
已关闭
omission of chemotherapy in the treatment of HER2-positive and hormone-receptor positive metastatic breast cancer – interim results from the randomized phase 3 DETECT V trial
22天前
已关闭
CDK4/6 Inhibitors in HER2-positive Metastatic Breast Cancer
26天前
已关闭
American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions
27天前
已完结
皖公网安备34019202002308
